Restoration of glucose counterregulation by islet transplantation in long-standing type 1 diabetes

Diabetes

Volumn 64, Issue 5, 2015, Pages 1713-1718

  Rickels, Michael R ^a   Fuller, Carissa ^a   Dalton Bakes, Cornelia ^a   Markmann, Eileen ^a   Palanjian, Maral ^a   Cullison, Kevin ^a   Tiao, Janice ^a   Kapoor, Shiv ^a   Liu, Chengyang ^a   Naji, Ali ^a   Teff, Karen L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MONELL CHEMICAL SENSES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; C PEPTIDE; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; INSULIN; RAPAMYCIN; TACROLIMUS; GLUCOSE BLOOD LEVEL;

ADRENALIN RELEASE; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; GLUCAGON RELEASE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HUMAN; HYPERINSULINEMIA; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; LONGITUDINAL STUDY; MALE; PANCREAS GRAFT REJECTION; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; GLUCOSE CLAMP TECHNIQUE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 84964693764     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1620     Document Type: Article

References (25)

1. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-1912.
2. Cryer PE. Mechanisms of hypoglycemia- Associated autonomic failure in diabetes. N Engl J Med 2013;369:362-372.
3. Pedersen-Bjergaard U, Pramming S, Heller SR, et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004;20:479-486.
4. Weinstock RS, Xing D, Maahs DM, et al.; T1D Exchange Clinic Network. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: Results from the T1D Exchange clinic registry. J Clin Endocrinol Metab 2013;98:3411-3419.
5. McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 2012;35:1897-1901.
6. Paty BW, Ryan EA, Shapiro AMJ, Lakey JRT, Robertson RP. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 2002;51:3428-3434.
7. Rickels MR, Schutta MH, Mueller R, et al. Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes 2005;54:3205-3211.
8. Rickels MR, Schutta MH, Mueller R, et al. Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients. J Clin Endocrinol Metab 2007;92:873-879.
9. Rickels MR, Liu C, Shlansky-Goldberg RD, et al. Improvement in b-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes 2013;62:2890-2897.
10. Rickels MR, Kong SM, Fuller C, et al. Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures. Am J Physiol Endocrinol Metab 2014;306: E1217-E1224.
11. Bernroider E, Brehm A, Krssak M, et al. The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes. J Clin Endocrinol Metab 2005;90:5559-5565.
12. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 1995;18:517-522.
13. Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004;53:955-962.
14. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: A report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013;36:1384-1395.
15. Gerich JE, Lorenzi M, Tsalikian E, Karam JH. Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion. Diabetes 1976;25:65-71.
16. White NH, Gingerich RL, Levandoski LA, Cryer PE, Santiago JV. Plasma pancreatic polypeptide response to insulin-induced hypoglycemia as a marker for defective glucose counterregulation in insulin-dependent diabetes mellitus. Diabetes 1985;34:870-875.
17. Zhou H, Zhang T, Bogdani M, et al. Intrahepatic glucose flux as a mechanism for defective intrahepatic islet alpha-cell response to hypoglycemia. Diabetes 2008;57:1567-1574.
18. Bellin MD, Parazzoli S, Oseid E, et al. Defective glucagon secretion during hypoglycemia after intrahepatic but not nonhepatic islet autotransplantation. Am J Transplant 2014;14:1880-1886.
19. Paty BW, Senior PA, Lakey JR, Shapiro AM, Ryan EA. Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects. Diabetes Technol Ther 2006;8:165-173.
20. Gorn L, Faradji RN, Messinger S, et al. Impact of islet transplantation on glycemic control as evidenced by a continuous glucose monitoring system. J Diabetes Sci Tech 2008;2:221-228.
21. Vantyghem MC, Raverdy V, Balavoine AS, et al. Continuous glucose monitoring after islet transplantation in type 1 diabetes: An excellent graft function (b-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (b-score greater than 3). J Clin Endocrinol Metab 2012;97:E2078-E2083.
22. Fradkin J, Shamoon H, Felig P, Sherwin RS. Evidence for an important role of changes in rather than absolute concentrations of glucagon in the regulation of glucose production in humans. J Clin Endocrinol Metab 1980;50: 698-703.
23. Eigler N, Saccà L, Sherwin RS. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: A model for stressinduced hyperglycemia. J Clin Invest 1979;63:114-123.
24. Enoksson S, Caprio SK, Rife F, Shulman GI, Tamborlane WV, Sherwin RS. Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia. J Clin Endocrinol Metab 2003;88:1503- 1511.
25. Ang M, Meyer C, Brendel MD, Bretzel RG, Linn T. Magnitude and mechanisms of glucose counterregulation following islet transplantation in patients with type 1 diabetes suffering from severe hypoglycaemic episodes. Diabetologia 2014;57:623-632.